2m 2m 2m 2m 2m 2m 2m
SPYGLASS (SGP)
NASDAQ
$28.16+$0.45 (+1.61%)
Price as of Oct 22, 2026 7:30 PM EDT- $926.8MMarket Cap
- N/A1-Year Change
- BiotechnologyIndustry
SPYGLASS (SGP)
$28.16+$0.45 (+1.61%)
Annual
Quarterly
12/31/2025 | ||
|---|---|---|
Income Statement | ||
Total Operating Revenue | N/A N/A | |
Cost of Revenue | N/A N/A | |
Gross Profit | 0 N/A | |
Sales and Marketing Expense | 1.0M N/A | |
Research and Development Expense | -29.2M N/A | |
Depreciation and Amortization Expense | 612,000 N/A | |
Total Operating Expenses | 41.4M N/A | |
Operating Profit | -41.4M N/A | |
Interest Income | 3.1M N/A | |
Interest Expense | N/A N/A | |
Interest Income and Expense and Net | 3.1M N/A | |
Total Nonoperating Income and Expense | 1.6M N/A | |
Income before Taxes | -39.9M N/A | |
Income Taxes | 0 N/A | |
Extraordinary Items | N/A N/A | |
Net Income | -39.9M N/A | |
Net Income from Continuing Operations Applicable to Common | -39.9M N/A | |
Basic EPS and Net Income | -17.98 N/A | |
Diluted EPS and Net Income | -17.98 N/A | |
Basic Weighted Average Shares | 2.2M N/A | |
Diluted Weighted Average Shares | 2.2M N/A | |
Balance Sheet | ||
Cash and Cash Equivalents | 96.4M N/A | |
Short-Term Investments | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 96.4M N/A | |
Total Current Assets | 108.8M N/A | |
Accumulated Depreciation | 1.1M N/A | |
Property and Plant and Equipment and Net | 2.3M N/A | |
Total Long-Term Assets | 492,000 N/A | |
Total Assets | 115.9M N/A | |
Income Taxes Payable | N/A N/A | |
Total Short-Term Debt | N/A N/A | |
Total Current Liabilities | 8.6M N/A | |
Total Long-Term Debt | N/A N/A | |
Total Long-Term Liabilities | 4.3M N/A | |
Total Liabilities | 10.2M N/A | |
Retained Earnings | -104.7M N/A | |
Total Stockholders Equity | -98.8M N/A | |
Total Shares Outstanding | 2.2M N/A | |
Cash Flow | ||
Cash from Operating Activities | -32.7M N/A | |
Capital Expenditures | 789,000 N/A | |
Cash from Investing Activities | -11.8M N/A | |
Dividends Paid | N/A N/A | |
Cash from Financing Activities | 124.6M N/A | |
Financials Ratio | ||
Gross Margin | N/A N/A | |
Operating Margin | N/A N/A | |
Return on Assets | N/A N/A | |
Return on Equity | N/A N/A | |
Revenue Growth | N/A N/A | |
Current Ratio | N/A N/A | |
Cash Ratio | N/A N/A | |
Debt-to-Equity Ratio | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow